The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019

meeting report

Ga Won Yim, Dong Hoon Suh, Jae Weon Kim, Seung Cheol Kim, Young Tae Kim

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of gynecologic oncologic research and treatment. The scope of this meeting included recent clinical trials and updates in gynecologic oncology, advances in ovarian cancer treatment, targeted therapy and immunotherapy in gynecologic cancer, management of hereditary gynecologic cancer, and newly revised staging of cervical cancer. As expected, the ongoing debate regarding the recent clinical trial on minimally invasive surgery for early-stage cervical cancer was addressed throughout the congress and the initial outline of the KSGO position statement was open for discussion. The meeting was an opportunity for all participants to come together and explore scientific insights of gynecologic cancer.

Original languageEnglish
Pages (from-to)e91
JournalJournal of Gynecologic Oncology
Volume30
Issue number4
DOIs
StatePublished - 1 Jul 2019

Fingerprint

Uterine Cervical Neoplasms
Clinical Trials
Neoplasms
Minimally Invasive Surgical Procedures
Korea
Ovarian Neoplasms
Immunotherapy
Therapeutics
Research

Keywords

  • Endometrial Neoplasms
  • Immunotherapy
  • Molecular Targeted Therapy
  • Ovarian Neoplasms
  • Uterine Cervical Neoplasms

Cite this

Yim, Ga Won ; Suh, Dong Hoon ; Kim, Jae Weon ; Kim, Seung Cheol ; Kim, Young Tae. / The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019 : meeting report. In: Journal of Gynecologic Oncology. 2019 ; Vol. 30, No. 4. pp. e91.
@article{a690cba34e6f46ae8585292cb44b9f1a,
title = "The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report",
abstract = "The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of gynecologic oncologic research and treatment. The scope of this meeting included recent clinical trials and updates in gynecologic oncology, advances in ovarian cancer treatment, targeted therapy and immunotherapy in gynecologic cancer, management of hereditary gynecologic cancer, and newly revised staging of cervical cancer. As expected, the ongoing debate regarding the recent clinical trial on minimally invasive surgery for early-stage cervical cancer was addressed throughout the congress and the initial outline of the KSGO position statement was open for discussion. The meeting was an opportunity for all participants to come together and explore scientific insights of gynecologic cancer.",
keywords = "Endometrial Neoplasms, Immunotherapy, Molecular Targeted Therapy, Ovarian Neoplasms, Uterine Cervical Neoplasms",
author = "Yim, {Ga Won} and Suh, {Dong Hoon} and Kim, {Jae Weon} and Kim, {Seung Cheol} and Kim, {Young Tae}",
year = "2019",
month = "7",
day = "1",
doi = "10.3802/jgo.2019.30.e91",
language = "English",
volume = "30",
pages = "e91",
journal = "Journal of gynecologic oncology",
issn = "2005-0380",
publisher = "Korean Society of Gynecologic Oncology and Colposcopy",
number = "4",

}

The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019 : meeting report. / Yim, Ga Won; Suh, Dong Hoon; Kim, Jae Weon; Kim, Seung Cheol; Kim, Young Tae.

In: Journal of Gynecologic Oncology, Vol. 30, No. 4, 01.07.2019, p. e91.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019

T2 - meeting report

AU - Yim, Ga Won

AU - Suh, Dong Hoon

AU - Kim, Jae Weon

AU - Kim, Seung Cheol

AU - Kim, Young Tae

PY - 2019/7/1

Y1 - 2019/7/1

N2 - The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of gynecologic oncologic research and treatment. The scope of this meeting included recent clinical trials and updates in gynecologic oncology, advances in ovarian cancer treatment, targeted therapy and immunotherapy in gynecologic cancer, management of hereditary gynecologic cancer, and newly revised staging of cervical cancer. As expected, the ongoing debate regarding the recent clinical trial on minimally invasive surgery for early-stage cervical cancer was addressed throughout the congress and the initial outline of the KSGO position statement was open for discussion. The meeting was an opportunity for all participants to come together and explore scientific insights of gynecologic cancer.

AB - The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of gynecologic oncologic research and treatment. The scope of this meeting included recent clinical trials and updates in gynecologic oncology, advances in ovarian cancer treatment, targeted therapy and immunotherapy in gynecologic cancer, management of hereditary gynecologic cancer, and newly revised staging of cervical cancer. As expected, the ongoing debate regarding the recent clinical trial on minimally invasive surgery for early-stage cervical cancer was addressed throughout the congress and the initial outline of the KSGO position statement was open for discussion. The meeting was an opportunity for all participants to come together and explore scientific insights of gynecologic cancer.

KW - Endometrial Neoplasms

KW - Immunotherapy

KW - Molecular Targeted Therapy

KW - Ovarian Neoplasms

KW - Uterine Cervical Neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85067289486&partnerID=8YFLogxK

U2 - 10.3802/jgo.2019.30.e91

DO - 10.3802/jgo.2019.30.e91

M3 - Article

VL - 30

SP - e91

JO - Journal of gynecologic oncology

JF - Journal of gynecologic oncology

SN - 2005-0380

IS - 4

ER -